Evidence map›Paper›PMID 33949409›Full record

ArticleLab on a chip2021

Mechanotransduction-on-chip: vessel-chip model of endothelial YAP mechanobiology reveals matrix stiffness impedes shear response.

Brandon K Walther, Navaneeth Krishna Rajeeva Pandian, Karli A Gold, Ecem S Kiliç, Vineeth Sama, Jianhua Gu, Akhilesh K Gaharwar, Anthony Guiseppi-Elie, John P Cooke, Abhishek Jain

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Evidence for Drop-Like Nuclear Deformation in Sheared Endothelial Monolayers.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  10. Vascular endothelial integration of multiple biophysical stimuli.Frontiers in cardiovascular medicine · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Bioengineering vascularization.Development (Cambridge, England) · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Engineering Organ-on-a-Chip Systems for Vascular Diseases.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Brandon K WaltherDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu and Department of Cardiovascular Sciences, Houston Methodist Institute for Academic Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, Texas 77030, USA. jgu@houstonmethodist.org jpcooke@houstonmethodist.org.ORCID 0000-0002-4086-8897
Navaneeth Krishna Rajeeva PandianDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu.ORCID 0000-0003-2623-3630
Karli A GoldDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu.
Ecem S KiliçDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu.ORCID 0000-0002-3106-1362
Vineeth SamaDepartment of Biomedical Engineering, Clemson University, Clemson, South Carolina 29634, USA. vsama@g.clemson.edu.ORCID 0000-0002-9173-1161
Jianhua GuDepartment of Cardiovascular Sciences, Houston Methodist Institute for Academic Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, Texas 77030, USA. jgu@houstonmethodist.org jpcooke@houstonmethodist.org.
Akhilesh K GaharwarDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu and Department of Materials Science, Texas A&M University, College Station, Texas 77843, USA.ORCID 0000-0002-0284-0201
Anthony Guiseppi-ElieDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu and Department of Cardiovascular Sciences, Houston Methodist Institute for Academic Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, Texas 77030, USA. jgu@houstonmethodist.org jpcooke@houstonmethodist.org and ABTECH Scientific, Inc., Biotechnology Research Park, 800 East Leigh Street, Richmond, Virginia 23219, USA and Department of Biomedical Engineering, Anderson University, Anderson, South Carolina 29621, USA. aguiseppi@andersonuniversity.edu.ORCID 0000-0003-3218-9285
John P CookeDepartment of Cardiovascular Sciences, Houston Methodist Institute for Academic Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, Texas 77030, USA. jgu@houstonmethodist.org jpcooke@houstonmethodist.org.ORCID 0000-0003-0033-9138
Abhishek JainDepartment of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, USA. brandonwalther1@tamu.edu navnkri@tamu.edu kgold@tamu.edu ecem_simay@tamu.edu gaharwar@tamu.edu a.jain@tamu.edu and Department of Cardiovascular Sciences, Houston Methodist Institute for Academic Medicine, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, Texas 77030, USA. jgu@houstonmethodist.org jpcooke@houstonmethodist.org and Department of Medical Physiology, College of Medicine, Texas A&M Health Science Center, Bryan, TX 77807, USA.ORCID 0000-0003-2235-5139
Houston Methodist · USMitchell Institute · USClemson University · USTexas A&M Health Science Center · US

Funding

Reversal of Heart Failure: Role of Vascular RecoveryR01HL148338 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU, COOKE, JOHN P · 2020 to 2023
$2.8M
Role of S-nitrosylation in TransdifferentiationR01HL133254 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU, COOKE, JOHN P · 2018 to 2021
$1.6M
An artery-on-a-chip system containing blood outgrowth endothelium as a model of vaso-occlusion and drug testing in sickle cell diseaseR21EB025945 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI JAIN, ABHISHEK · 2018 to 2020
$581k
NHLBI NIH HHS R01 HL133254NHLBI NIH HHS R01 HL148338NIBIB NIH HHS R21 EB025945
6 · The paper itself

Abstract

Endothelial mechanobiology is a key consideration in the progression of vascular dysfunction, including atherosclerosis. However mechanistic connections between the clinically associated physical stimuli, vessel stiffness and shear stress, and how they interact to modulate plaque progression remain incompletely characterized. Vessel-chip systems are excellent candidates for modeling vascular mechanobiology as they may be engineered from the ground up, guided by the mechanical parameters present in human arteries and veins, to recapitulate key features of the vasculature. Here, we report extensive validation of a vessel-chip model of endothelial yes-associated protein (YAP) mechanobiology, a protein sensitive to both matrix stiffness and shearing forces and, importantly, implicated in atherosclerotic progression. Our model captures the established endothelial mechanoresponse, with endothelial alignment, elongation, reduction of adhesion molecules, and YAP cytoplasmic retention under high laminar shear. Conversely, we observed disturbed morphology, inflammation, and nuclear partitioning under low, high, and high oscillatory shear. Examining targets of YAP transcriptional co-activation, connective tissue growth factor (CTGF) is strongly downregulated by high laminar shear, whereas it is strongly upregulated by low shear or oscillatory flow. Ankyrin repeat domain 1 (ANKRD1) is only upregulated by high oscillatory shear. Verteporfin inhibition of YAP reduced the expression of CTGF but did not affect ANKRD1. Lastly, substrate stiffness modulated the endothelial shear mechanoresponse. Under high shear, softer substrates showed the lowest nuclear localization of YAP whereas stiffer substrates increased nuclear localization. Low shear strongly increased nuclear localization of YAP across stiffnesses. Together, we have validated a model of endothelial mechanobiology and describe a clinically relevant biological connection between matrix stiffness, shear stress, and endothelial activation via YAP mechanobiology.

Indexed as

Adaptor Proteins, Signal TransducingAtherosclerosisBiophysicsHumansMechanotransduction, CellularTranscription FactorsAdaptor Proteins, Signal TransducingTranscription Factors

Identifiers

PMID33949409
PMCPMC9761985
OpenAlexW3137959940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.